Role of the PP2A Pathway in Cholangiocarcinoma: State of the Art and Future Perspectives

Ion Cristóbal; Angela Lamarca

doi:10.3390/cancers14215422

Role of the PP2A Pathway in Cholangiocarcinoma: State of the Art and Future Perspectives

Cancers (Basel). 2022 Nov 3;14(21):5422. doi: 10.3390/cancers14215422.

Authors

Ion Cristóbal¹, Angela Lamarca²

Affiliations

¹ Cancer Unit for Research on Novel Therapeutic Targets, Oncohealth Institute, IIS-Fundación Jiménez Díaz-UAM, 28040 Madrid, Spain.
² Medical Oncology Department, Oncohealth Institute, IIS-Fundación Jiménez Díaz-UAM, 28040 Madrid, Spain.

Abstract

Cholangiocarcinoma represents a heterogeneous disease at both a clinical and molecular level [...].

Publication types

Editorial

Grants and funding

Angela Lamarca received funding from the Spanish Society of Medical Oncology (SEOM) Fellowship Programme (Return Fellowship) and the European Union’s Horizon 2020 Research and Innovation Programme [grant number 825510, ESCALON].